This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Candesartan cilexetil and hydrochlorothiazide

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20221013

Version

4

Spl Product Data Elements

candesartan cilexetil and hydrochlorothiazide candesartan cilexetil and hydrochlorothiazide CANDESARTAN CILEXETIL CANDESARTAN HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE CARBOXYMETHYLCELLULOSE CALCIUM STARCH, CORN CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES LACTOSE MONOHYDRATE MAGNESIUM STEARATE HYDROXYPROPYL CELLULOSE (110000 WAMW) WHITE TO OFF-WHITE OVAL 19;4 candesartan cilexetil and hydrochlorothiazide candesartan cilexetil and hydrochlorothiazide CANDESARTAN CILEXETIL CANDESARTAN HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE CARBOXYMETHYLCELLULOSE CALCIUM STARCH, CORN CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES LACTOSE MONOHYDRATE MAGNESIUM STEARATE HYDROXYPROPYL CELLULOSE (110000 WAMW) WHITE TO OFF-WHITE OVAL 19;5 candesartan cilexetil and hydrochlorothiazide candesartan cilexetil and hydrochlorothiazide CANDESARTAN CILEXETIL CANDESARTAN HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE CARBOXYMETHYLCELLULOSE CALCIUM STARCH, CORN CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES LACTOSE MONOHYDRATE MAGNESIUM STEARATE HYDROXYPROPYL CELLULOSE (110000 WAMW) WHITE TO OFF-WHITE OVAL 41;6

Application Number

ANDA203466

Brand Name

Candesartan cilexetil and hydrochlorothiazide

Generic Name

candesartan cilexetil and hydrochlorothiazide

Product Ndc

70771-1327

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1325-0 in bottle of 1000 tablets Candesartan Cilexetil and Hydrochlorothiazide Tablets USP, 16 mg/12.5 mg R x only 1000 tablets NDC 70771-1326-0 in bottle of 1000 tablets Candesartan Cilexetil and Hydrochlorothiazide Tablets USP, 32 mg/12.5 mg R x only 1000 tablets NDC 70771-1327-0 in bottle of 1000 tablets Candesartan Cilexetil and Hydrochlorothiazide Tablets USP, 32 mg/25 mg R x only 1000 tablets Candesartan cilexetil and hydrochlorothiazide tablets Candesartan cilexetil and hydrochlorothiazide tablets Candesartan cilexetil and hydrochlorothiazide tablets

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.